Interpreting the mechanisms of continuous renal replacement therapy in sepsis: The peak concentration hypothesis

被引:260
作者
Ronco, C
Tetta, C
Mariano, F
Wratten, ML
Bonello, M
Bordoni, V
Cardona, X
Inguaggiato, P
Pilotto, L
d'Intini, V
Bellomo, R
机构
[1] St Bortolo Hosp, Dept Nephrol, I-36100 Vicenza, Italy
[2] St Giovanni Bosco Hosp, Dept Nephrol, Turin, Italy
[3] Austin & Repatriat Med Ctr, Heidelberg, Vic, Australia
关键词
acute renal failure; multiple organ dysfunction syndrome; sepsis; continuous renal replacement therapy; homeostasis; peak concentration;
D O I
10.1046/j.1525-1594.2003.07289.x
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Severe sepsis and septic shock are the primary causes of multiple organ dysfunction syndrome ( MODS), which is the most frequent cause of death in intensive care unit patients. Many water-soluble mediators with pro- and anti-inflammatory action such as TNF, IL-6, IL-8, and IL-10 play a strategic role in septic syndrome. In intensive care medicine, blocking any one mediator has not led to a measurable outcome improvement in patients with sepsis. CRRT is a continuously acting therapy, which removes in a nonselective way pro- and anti-inflammatory mediators; the peak concentration hypothesis" is the concept of cutting peaks of soluble mediators through continuous hemofiltration. Furthermore, there is evidence of increased efficacy of high-volume hemofiltration compared to conventional CVVH, and other blood purification techniques that utilize large-pore membranes or sorbent plasmafiltration are conceptually interesting.
引用
收藏
页码:792 / 801
页数:10
相关论文
共 88 条
[1]   p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock - A randomized controlled multicenter trial [J].
Abraham, E ;
Glauser, MP ;
Butler, T ;
Garbino, J ;
Gelmont, D ;
Laterre, PF ;
Kudsk, K ;
Bruining, HA ;
Otto, C ;
Tobin, E ;
Zwingelstein, C ;
Lesslauer, W ;
Leighton, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (19) :1531-1538
[2]  
Adib-Conquy M, 2001, J LEUKOCYTE BIOL, V70, P30
[3]  
Bellomo R, 1995, New Horiz, V3, P760
[4]  
Bellomo R, 1998, KIDNEY INT, V53, pS106
[5]   CONTINUOUS VENOVENOUS HEMOFILTRATION WITH DIALYSIS REMOVES CYTOKINES FROM THE CIRCULATION OF SEPTIC PATIENTS [J].
BELLOMO, R ;
TIPPING, P ;
BOYCE, N .
CRITICAL CARE MEDICINE, 1993, 21 (04) :522-526
[6]   INTERLEUKIN-6 AND INTERLEUKIN-8 EXTRACTION DURING CONTINUOUS VENOVENOUS HEMODIAFILTRATION IN SEPTIC ACUTE-RENAL-FAILURE [J].
BELLOMO, R ;
TIPPING, P ;
BOYCE, N .
RENAL FAILURE, 1995, 17 (04) :457-466
[7]   The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia [J].
Bellomo, R ;
Kellum, JA ;
Gandhi, CR ;
Pinsky, MR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (05) :1429-1436
[8]   Sepsis: A new hypothesis for pathogenesis of the disease process [J].
Bone, RC ;
Grodzin, CJ ;
Balk, RA .
CHEST, 1997, 112 (01) :235-243
[9]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[10]   Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: Identification of interleukin-10 as a major functional deactivator of human monocytes [J].
Brandtzaeg, P ;
Osnes, L ;
Ovstebo, R ;
Joo, GB ;
Westvik, AB ;
Kierulf, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (01) :51-60